Treasurer of the State of North Carolina - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
Treasurer of the State of North Carolina ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$626,000
-21.0%
18,925
+1.6%
0.00%
-25.0%
Q4 2021$792,000
-3.4%
18,625
+0.6%
0.00%
-20.0%
Q3 2021$820,000
-19.3%
18,505
+3.5%
0.01%
-16.7%
Q2 2021$1,016,000
-27.7%
17,876
-4.7%
0.01%
-33.3%
Q1 2021$1,405,000
-13.7%
18,766
-0.3%
0.01%
-18.2%
Q4 2020$1,628,000
+41.9%
18,816
+0.3%
0.01%
+22.2%
Q3 2020$1,147,000
+46.9%
18,766
-0.1%
0.01%
+50.0%
Q2 2020$781,000
-26.5%
18,786
-49.2%
0.01%
-33.3%
Q1 2020$1,062,000
-47.6%
36,995
+31.9%
0.01%
-47.1%
Q4 2019$2,025,000
-48.3%
28,055
+0.5%
0.02%
-51.4%
Q3 2019$3,918,000
-40.3%
27,925
-22.1%
0.04%
-12.5%
Q2 2019$6,563,000
+23.2%
35,845
+7.1%
0.04%
+17.6%
Q1 2019$5,325,000
+76.0%
33,478
+6.0%
0.03%
+54.5%
Q4 2018$3,025,000
-32.2%
31,577
-0.0%
0.02%
-21.4%
Q3 2018$4,462,000
+179.4%
31,587
+209.7%
0.03%
+64.7%
Q2 2018$1,597,00010,2000.02%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 99,306$14,027,0005.76%
Casdin Capital, LLC 312,000$44,070,0005.36%
Palo Alto Investors LP 840,372$118,703,0004.80%
BB BIOTECH AG 1,071,373$151,331,0004.00%
TRV GP II, LLC 37,362$5,277,0003.10%
Eversept Partners, LP 43,621$6,161,4662.70%
RA Capital Management 350,933$49,569,0002.65%
Eventide Asset Management 494,000$69,778,0002.56%
OAK RIDGE INVESTMENTS LLC 241,099$34,055,0001.88%
SUFFOLK CAPITAL MANAGEMENT LLC 93,000$13,136,0001.87%
View complete list of SAGE THERAPEUTICS INC shareholders